azacitidine has been researched along with Carcinogenesis in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 30 (85.71) | 24.3611 |
| 2020's | 5 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, HT; Jung, BD; Kim, DY; Lee, R; Park, J; Ra, CS; Rhee, KJ | 1 |
| Fu, Y; Hu, M; Ji, J; Jiang, C; Li, L; Nie, Q; Xu, H; Zhang, B; Zhou, X | 1 |
| Chen, J; Chen, Z; Chi, J; Deng, M; Hu, J; Huang, L; Li, J; Li, Q; Luo, Z; Tao, K; Wang, G; Wang, L; Wang, Z; Zhang, H; Zhou, C | 1 |
| Chen, N; Cheng, L; Dai, L; Deng, H; Dong, Z; Fang, C; Fu, J; Ji, Y; Li, J; Liu, Y; Shi, G; Su, X; Wang, H; Wang, W; Yang, Y; Yu, Y; Zhang, H; Zhang, S | 1 |
| Albulescu, A; Anton, G; Badiu, CV; Bostan, M; Botezatu, A; Dobrescu, R; Fudulu, A; Grancea, C; Huica, I; Iancu, IV; Manda, DA; Mihaila, M; Plesa, A; Vladoiu, SV | 1 |
| Demehri, S; Ghim, SJ; Ha, T; Jenson, AB; Joh, JJ; Khanal, S; Redman, RA; Strickley, JD | 1 |
| Bai, Y; Chang, D; Li, M; Liu, C; Lv, D; Sun, G; Zhang, X | 1 |
| Evers, BM; Kim, JT; Weiss, HL | 1 |
| Chen, Q; Hu, YH; Li, XM; Li, XN; Lin, C; Lu, YX; Zhang, F; Zhang, JM; Zhang, W; Zhang, WJ | 1 |
| Belardelli, F; Buoncervello, M; Canini, I; Capone, I; De Angelis, M; Del Vecchio, G; Fragale, A; Gabriele, L; Giuliani, C; Leone, C; Licursi, V; Negri, R; Parlato, S; Presutti, C; Romagnoli, G; Toschi, E | 1 |
| Arentsen-Peters, TCJM; Baruchel, A; Danen-van Oorschot, AA; de Haas, V; Fornerod, M; Larmonie, NSD; Obulkasim, A; Pieters, R; Reinhardt, D; Sonneveld, E; Trka, J; Valerio, D; van den Heuvel-Eibrink, MM; Zimmermann, M; Zwaan, CM | 1 |
| Amarante-Mendes, GP; Calle, Y; Castro, FA; De Carvalho, DD; Hamerschlak, N; Jacysyn, JF; Jones, GE; Pagnano, KB; Pereira, WO; Ribeiro, BF; Sardinha, LR; Zanichelli, MA; Zenteno, ME | 1 |
| Barros-Silva, D; Carneiro, I; Carvalho, AL; Costa-Pinheiro, P; Duarte, H; Evangelista, AF; Graça, I; Henrique, R; Jerónimo, C; Marques, MM; Martins, AT; Oliveira, J; Sousa, EJ | 1 |
| Gailhouste, L; Hatada, I; Liew, LC; Nakagama, H; Ochiya, T; Tanaka, Y; Yasukawa, K | 1 |
| He, X; Li, S; Pei, L; Ren, G; Sun, R; Xiang, Q; Xiang, T | 1 |
| Alibés, A; Alonso, S; Fece de la Cruz, F; González, B; Samuelsson, JK | 1 |
| Aumann, K; Daskalakis, M; Erlacher, M; Flotho, C; Gallego-Villar, L; Hartmann, M; Krombholz, CF; Lipka, DB; Niemeyer, CM; Panda, PK; Plass, C; Sahoo, SS; Wlodarski, MW | 1 |
| Cui, Y; Ding, M; Gao, Y; Li, X; Li, Y; Singh, N; Tian, R; Wu, X; Yang, Y | 1 |
| Brock, MV; Guo, M; Herman, JG; Licchesi, JD; Liu, X; Pei, X; Yang, Y; Yue, W; Zhang, X | 1 |
| Akiyama, Y; Hashimoto, Y; Yuasa, Y | 1 |
| Brewer, MA; Meng, F; Sun, G; Yu, Y; Zhong, M | 1 |
| Bai, R; Feng, G; Song, M; Yuan, H; Zhang, J; Zhang, Y; Zheng, J | 1 |
| Chen, X; Liu, Y; Long, Q; Meng, S; Ren, K; Song, N; Xie, Y; Zhao, X | 1 |
| Cho, YG; Han, J; Han, JY; Hong, SH; Hwang, JA; Kim, DH; Kim, Y; Kim, YH; Lee, J; Lee, YS; Shim, YM | 1 |
| Yang, WT; Zheng, PS | 1 |
| Bai, SY; Jiao, F; Ma, Y; Wang, J; Wang, X; Yan, ZH; Yu, Y; Yue, Z | 1 |
| Abba, MC; Cattaneo, ER; Coleman, RA; Garcia-Fabiani, MB; Gonzalez-Baro, MR; Lacunza, E; Montanaro, MA; Pellon-Maison, M; Quiroga, IY; Soler-Gerino, MC | 1 |
| Chen, WZ; Chen, XY; Huang, SH; Liu, JM; Liu, ZL; Long, XH; Peng, AF; Zhang, ZH; Zhou, YF | 1 |
| Fu, X; Han, W; Li, X; Mei, Q; Nie, J | 1 |
| Acun, T; Arango, D; Demir, K; Oztas, E; Yakicier, MC | 1 |
| Gao, D; Guo, M; Herman, JG | 1 |
| Cao, B; Chen, R; Di, C; Guo, M; Lu, Y; Lu, ZJ; Song, N; Yang, Y; Zhang, M | 1 |
| Fan, Y; Feng, Y; Kelly, K; Li, C; Li, L; Mu, J; Oberst, M; Peng, W; Ren, G; Tao, Q; Xiang, T; Ying, Y | 1 |
| Chang, KW; Chiang, WF; Chu, TH; Gong, NR; Lin, SC; Liu, CJ; Wu, CH; Yang, CC | 1 |
| D'Alessandro, AM; Di Clemente, L; Di Pasquale, B; Dolo, V; Festuccia, C; Gravina, GL; Mancini, A; Marampon, F; Muzi, P; Ranieri, G | 1 |
2 review(s) available for azacitidine and Carcinogenesis
| Article | Year |
|---|---|
Decitabine: a promising epi-immunotherapeutic agent in solid tumors.
Topics: Animals; Azacitidine; Carcinogenesis; Clinical Trials as Topic; Decitabine; DNA Methylation; DNA Modification Methylases; Humans; Immunotherapy; Neoplasms; Tumor Escape | 2015 |
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Carcinogenesis; CpG Islands; Decitabine; DNA Damage; DNA Methylation; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Resistance, Neoplasm; Epigenesis, Genetic; Fluorouracil; Humans; Molecular Targeted Therapy; Neoplasms; Prognosis; Promoter Regions, Genetic; Tumor Suppressor Proteins | 2016 |
33 other study(ies) available for azacitidine and Carcinogenesis
| Article | Year |
|---|---|
5-Azacytidine (5-aza) Induces p53-associated Cell Death Through Inhibition of DNA Methyltransferase Activity in Hep3B and HT-29 Cells.
Topics: Azacitidine; Carcinogenesis; Cell Death; Cell Line, Tumor; DNA; DNA Methylation; DNA Modification Methylases; Genes, p53; HT29 Cells; Humans; Tumor Suppressor Protein p53 | 2023 |
WIF1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt/β-catenin signaling pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Azacitidine; beta Catenin; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Decitabine; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Wnt Signaling Pathway | 2023 |
AGR2 is controlled by DNMT3a-centered signaling module and mediates tumor resistance to 5-Aza in colorectal cancer.
Topics: Azacitidine; Caco-2 Cells; Carcinogenesis; Cell Line; Cell Line, Tumor; Colorectal Neoplasms; Disease Progression; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; HEK293 Cells; HT29 Cells; Humans; Mucoproteins; Oncogene Proteins; Prognosis; Promoter Regions, Genetic; Signal Transduction; Up-Regulation | 2019 |
Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Azoxymethane; bcl-Associated Death Protein; Carcinogenesis; Cell Line, Tumor; Colitis; Colon; Colonoscopy; Colorectal Neoplasms; Decitabine; Disease Models, Animal; Disease Progression; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Intestinal Mucosa; Male; Mice; Molecular Targeted Therapy; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Up-Regulation | 2020 |
Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Azacitidine; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Dioxygenases; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mixed Function Oxygenases; Promoter Regions, Genetic; Proto-Oncogene Proteins; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Young Adult | 2020 |
Human papillomavirus-positivity is associated with EREG down-regulation and promoter hypermethylation in head and neck squamous cell carcinoma.
Topics: Alphapapillomavirus; Azacitidine; Carcinogenesis; Cell Line, Tumor; Decitabine; Disease Progression; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Epigenesis, Genetic; Epiregulin; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Promoter Regions, Genetic; Squamous Cell Carcinoma of Head and Neck | 2020 |
Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer.
Topics: Aged; Animals; Azacitidine; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Male; Mice; MicroRNAs; Middle Aged; Neoplasm Invasiveness; Promoter Regions, Genetic; Xenograft Model Antitumor Assays | 2017 |
Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
Topics: Adaptor Proteins, Vesicular Transport; Azacitidine; Carcinogenesis; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Promoter Regions, Genetic; Receptors, Neurotensin; Signal Transduction | 2017 |
Hypermethylation of NDN promotes cell proliferation by activating the Wnt signaling pathway in colorectal cancer.
Topics: Animals; Azacitidine; Carcinogenesis; Cell Movement; Cell Proliferation; Colonic Neoplasms; Colorectal Neoplasms; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Low Density Lipoprotein Receptor-Related Protein-6; Male; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Staging; RNA, Small Interfering; Tumor Suppressor Proteins; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2017 |
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Carcinogenesis; Cell Line, Tumor; Colorectal Neoplasms; Dendritic Cells; Depsipeptides; Gene Expression Regulation, Neoplastic; Humans; Interferon Regulatory Factor-7; Interferon Regulatory Factors; Interferon-alpha; Interferon-gamma; Nitric Oxide Synthase Type II; Receptors, Cytokine; Receptors, Interferon; Signal Transduction | 2017 |
MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Topics: Adolescent; Azacitidine; Carcinogenesis; Cell Line, Tumor; Child; Child, Preschool; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Epigenesis, Genetic; Exons; Female; Gene Expression Regulation, Leukemic; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Trans-Activators; Tumor Suppressor Proteins | 2018 |
BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy.
Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Carcinogenesis; DNA Methylation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Promoter Regions, Genetic; Protein Kinase Inhibitors; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Wiskott-Aldrich Syndrome Protein | 2017 |
MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Topics: Aged; Azacitidine; Base Sequence; Carcinogenesis; Cell Line, Tumor; Cohort Studies; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Regulatory Networks; Humans; Male; MicroRNAs; Middle Aged; Phenotype; Promoter Regions, Genetic; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-myc; Response Elements; RNA, Messenger; Signal Transduction; Up-Regulation | 2018 |
Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells.
Topics: Animals; Azacitidine; Carcinogenesis; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Hepatocytes; Humans; Liver; Liver Neoplasms; Mice; Mice, Nude | 2018 |
KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; CpG Islands; Decitabine; DNA Methylation; DNA-Binding Proteins; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Middle Aged; Promoter Regions, Genetic; Signal Transduction; Stomach; Stomach Neoplasms; Transcription Factors; Tumor Suppressor Proteins; Up-Regulation | 2018 |
Epigenetic and transcriptional dysregulation of VWA2 associated with a MYC-driven oncogenic program in colorectal cancer.
Topics: Aged; Azacitidine; Biomarkers, Tumor; Calcium-Binding Proteins; Carcinogenesis; Cell Line, Tumor; Colorectal Neoplasms; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genetic Loci; Histone Code; Humans; Introns; Male; Middle Aged; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myc; RNA, Messenger; Transcription, Genetic; Up-Regulation; Wnt Proteins | 2018 |
Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Carcinogenesis; Humans; Leukemia, Myelomonocytic, Juvenile; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
Topics: Adult; Azacitidine; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cervix Uteri; CpG Islands; Disease Progression; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Promoter Regions, Genetic; SOXC Transcription Factors; Tumor Suppressor Proteins; Up-Regulation; Uterine Cervical Neoplasms | 2019 |
Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Animals; Apoptosis; Azacitidine; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta Catenin; Carcinogenesis; Carcinoma, Hepatocellular; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Decitabine; Epigenesis, Genetic; Female; G2 Phase Cell Cycle Checkpoints; Heterografts; Humans; Liver Neoplasms; Male; Methylation; Mice, Nude; Middle Aged; Neoplasm Proteins; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Transcription Factor 4; Transcription Factors; Wnt Signaling Pathway | 2013 |
Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer.
Topics: Azacitidine; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Methyl-CpG-Binding Protein 2; MicroRNAs; Nerve Tissue Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Stomach Neoplasms; Transfection | 2013 |
Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
Topics: Acetylation; Animals; Ascites; Azacitidine; Cadherins; Carcinogenesis; Cell Movement; Decitabine; DNA Methylation; DNA Modification Methylases; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C3H; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Nuclear Proteins; Ovarian Neoplasms; Spheroids, Cellular; Tumor Cells, Cultured; Twist-Related Protein 1 | 2013 |
DNA methylation of trefoil factor 1 (TFF1) is associated with the tumorigenesis of gastric carcinoma.
Topics: Apoptosis; Azacitidine; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; CpG Islands; DNA Methylation; Gene Expression Regulation; Humans; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Stomach Neoplasms; Trefoil Factor-1; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2014 |
Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development.
Topics: Antineoplastic Agents; Azacitidine; Carcinogenesis; Case-Control Studies; Cystadenoma, Serous; DNA Methylation; DNA, Neoplasm; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylases; Humans; Hydroxamic Acids; Methyltransferases; Neoplasm Staging; Ovarian Neoplasms; Ovary; rhoB GTP-Binding Protein | 2013 |
Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis.
Topics: Adult; Azacitidine; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Decitabine; DNA Methylation; Female; Gene Knockdown Techniques; Gene Silencing; Humans; Lung Neoplasms; Male; Neoplasm Invasiveness; Phenotype; Prognosis; Promoter Regions, Genetic; Proportional Hazards Models; Sulfotransferases | 2013 |
Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
Topics: Azacitidine; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Promoter Regions, Genetic; Protein Biosynthesis; Transcription, Genetic; Tumor Suppressor Proteins; Uterine Cervical Neoplasms | 2014 |
DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer.
Topics: Azacitidine; Breast Neoplasms; Carcinogenesis; Cell Proliferation; Decitabine; Disease Progression; DNA Methylation; Gene Expression Regulation, Neoplastic; Glucuronidase; Humans; MCF-7 Cells; Neoplasm Invasiveness; Promoter Regions, Genetic | 2014 |
Glycerol-3-phosphate acyltranferase-2 behaves as a cancer testis gene and promotes growth and tumorigenicity of the breast cancer MDA-MB-231 cell line.
Topics: Animals; Azacitidine; Breast Neoplasms; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Computer Simulation; Decitabine; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Glycerol-3-Phosphate O-Acyltransferase; Humans; Male; Mice; RNA, Small Interfering; Testis | 2014 |
Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP).
Topics: Adenosine Triphosphatases; Azacitidine; Carcinogenesis; Cell Cycle Proteins; Cell Line, Tumor; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MicroRNAs; Osteosarcoma; Signal Transduction; Valosin Containing Protein | 2015 |
PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.
Topics: Azacitidine; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Methylation; Down-Regulation; Enzyme Inhibitors; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Homozygote; Humans; Hydroxamic Acids; Liver Neoplasms; Microarray Analysis; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Sequence Deletion | 2015 |
Systematic study of novel lncRNAs in different gastrointestinal cancer cells.
Topics: Apoptosis; Azacitidine; Biomarkers, Tumor; Carcinogenesis; Cell Cycle; Cell Line, Tumor; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Real-Time Polymerase Chain Reaction; RNA, Long Noncoding; Sequence Analysis, RNA; Signal Transduction; Up-Regulation | 2016 |
DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Azacitidine; Breast; Breast Neoplasms; Carcinogenesis; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; CpG Islands; Decitabine; DNA Demethylation; DNA Methylation; Down-Regulation; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Female; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Glycogen Synthase Kinase 3; Humans; Neoplasm Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Wnt Signaling Pathway | 2016 |
miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
Topics: Azacitidine; Carcinogenesis; Carcinoma, Squamous Cell; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cells, Cultured; Decitabine; DNA Modification Methylases; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Insulin Receptor Substrate Proteins; Keratinocytes; MicroRNAs; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Oncogene Protein v-akt; RNA, Small Interfering; TOR Serine-Threonine Kinases | 2013 |
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinogenesis; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Epithelial Cells; Gene Expression; Glutathione S-Transferase pi; Humans; Male; Phenotype; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms | 2013 |